MedPath

A pilot single-arm study of the effects of remote cognitive behavioral therapy on somatic symptoms

Phase 2
Conditions
somatic symptoms
Registration Number
JPRN-UMIN000046138
Lead Sponsor
Graduate School of Medicine Chiba University Department of Cognitive Behavioral Physiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who are complicated by serious mental disorders such as DSM-5 neurocognitive disorder group, psychotic disorder, bipolar disorder, or substance-related disorder, and who are expected to discontinue cognitive behavioral therapy due to worsening of these symptoms. (2) Patients with mental retardation (referring to assessment scores such as JART-25: Japanese Adult Reading Test-25) or autism spectrum disorder (referring to AQ: Autism Spectrum Index, etc.). (3) Those who have a serious progressive physical disease that is expected to interrupt the study. (4) Patients who are judged by the principal investigator or the study psychologist to be inappropriate for the safe conduct of the study. (5) Persons whose physical symptoms involve litigation or compensation. Translated with www.DeepL.com/Translator (free version)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MOS 36-Item Short-Form Health Survey Physical component summary Pre vCBTp Post vCBTp
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath